References
- Crapo, J. D., Young, S. L., Fram, E. K., Pinkerton, K. E., Barry, B. E., and Crapo, R. 0. 1983. Morpho-metric characteristics of cells in the alveolar region of mammalian lungs. Am. Rev. Respir. Dis. 128:S42—S46.
- Dankovic, D. A., and Bailer, A. J. 1993. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model. Fundam. Appl. Toxicol. 22:20–25.
- Eger, E. I. II. 1990. Uptake and distribution. In Anesthesia, 3rd ed., ed. R. D. Miller, pp. 85–104. New York: Churchill Livingstone.
- Holaday, D. A. 1977. Absorption, biotransformation, and storage of halothane. Environ. Health Perspect. 21:165–169.
- Holaday, D. A., Fiserova-Bergerova, V., Latto, I. P., and Zumbiel, M. A. 1975. Resistance of isoflu-rane to biotransformation in man. Anesthesiology43:325–332.
- Jarabek, A. M., Fisher, J. W., Rubenstein, R., Lipscomb, J. C., Williams, R. J., Vinegar, A., and McDougal, J. N. 1994. Mechanistic insights aid the search for CFC substitutes: Risk assessment of HCFC-123 as an example. Risk Anal. 14:231–250.
- Lerman, Y., Winkler, E., Tirosh, M. S., Danon, Y., and Almog, S. 1991. Fatal accidental inhalation of bromochlorodifluoromethane (Halon 1211). Hum. Exp. Toxicol. 10:125–128.
- Lerou, J. G. C., Dirksen, R., Beneken Kolmer, H. H., and Booij, L. H. D. J. 1991. A system model for closed-circuit inhalation anesthesia I. Computer study. Anesthesiology 75:345–355.
- Overton, J. H., and Graham, R. C. 1993. The role of the respiratory tract in the uptake of inhaled gases and vapors. Toxicologist13(1):260.
- Sutton, T. S., Koblin, D. D., Gruenke, L. D., Weiskopf, R. B., Rampil, I. J., Waskell, L., and Eger, E. I. II. 1991. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth. Analg. 73:180–185.
- U.S. Environmental Protection Agency. 1994. SNAP Technical Background Document: Risk Screen on the Use of Substitutes for Class I Ozone-Depleting Substances, Fire Suppression and Explosion Protection (Halon Substitutes). Washington, DC: U.S. Environmental Protection Agency, Office of Air and Radiation, Stratospheric Protection Division.
- Vinegar, A., and Jepson, G. W. 1996. Cardiac sensitization thresholds of Halon replacement chemi-cals predicted in humans by physiologically based pharmacokinetic modeling. Risk Anal. 16(4): 571–579.
- Vinegar, A., Williams, R. J., Fisher, J. W., and McDougal, J. N. 1994. Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: A physiologically based pharmacokinetic model in the male Fischer 344 rat. Toxicol. Appl. Pharmacol. 129:103–113.
- Williams, R. J., Vinegar, A., McDougal, J. N., Jarabek, A. M., and Fisher, J. W. 1996. Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: A corollary approach to physiologically based pharmacokinetic modeling. Fundam. Appl. Toxicol. 30:55–66.
- Yasuda, N., Lockhart, S. H., Eger, E. I. II, Johnson, B. H., Freire, B. A., and Fassoulaki, A. 1991. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 74:489–498.